SCHEMBL19785700

SCHEMBL19785700

Brc1cccc(-c2ccc3ccc4c(-c5cccnc5)ccc5ccc2c3c54)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 12/20 0.50
CYP11B2 P19099 11/20 0.50
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
CYP19A1 P11511 3/20 0.49
CYP17A1 P05093 6/20 0.45
CYP3A4 P08684 5/20 0.45
KMT2A Q03164 3/20 0.41
RXFP1 Q9HBX9 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
PKM P14618 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
HSD17B1 P14061 1/20 0.41
CYP2B6 P20813 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16483371 0.87 CYP11B1 (0.54) CYP11B1CYP11B2ALDH1A1CYP19A1CYP17A1
SCHEMBL16483072 0.87 CYP11B1 (0.54) CYP11B1CYP11B2ALDH1A1CYP19A1CYP17A1
SCHEMBL16557784 0.87 CYP11B1 (0.50) CYP11B1CYP11B2KDM4EALDH1A1LMNA
SCHEMBL12666704 0.86 CYP11B1 (0.58) CYP11B1CYP11B2KDM4EALDH1A1LMNA
SCHEMBL16483670 0.85 CYP11B1 (0.52) CYP11B1CYP11B2ALDH1A1CYP19A1CYP17A1
SCHEMBL17880386 0.85 CYP11B1 (0.47) CYP11B1CYP11B2KDM4EALDH1A1LMNA
SCHEMBL13085336 0.85 CYP11B1 (0.58) CYP11B1CYP11B2KDM4EALDH1A1HPGD
SCHEMBL3860411 0.83 GUSB (0.44) KDM4EALDH1A1HPGDCYP3A4KMT2A
SCHEMBL16483043 0.83 CYP11B1 (0.50) CYP11B1CYP11B2CYP19A1CYP17A1CYP3A4
SCHEMBL16483398 0.83 CYP11B1 (0.50) CYP11B1CYP11B2CYP19A1CYP17A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11133477-B2 Heterocyclic compound and organic light emitting element using same LT MATERIALS CO., LTD. (KR) 2021-09-28 US disclosed
US-20190312211-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2019-10-10 US disclosed
WO-2018012845-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME 희성소재(주) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11133477-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, CYP1A1 CYP11B1 53/4885CYP11B2 64/4885KDM4E 3716/4885
US-20190312211-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, CYP1A1 CYP11B1 53/4885CYP11B2 64/4885KDM4E 3716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.